Order
254897-50-2
4,4'-(1,4-Phenylenedi-2,1-Ethenedily)Bis[N-(2-Ethyl-6-Methylphenyl)-N-Phenyl-Benzenamine
Order
2030-63-9
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine (Clofazimine)
1261609-97-5
1261456-41-0
1599440-12-6
1623109-08-9
2766584-67-0
1270012-79-7
Efmoroctocog alfa
1044511-01-4
Benralizumab
2713439-69-9
tert-Butyl ((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamate
1380723-44-3
Atezolizumab
159847-82-2
62515-68-6
1227507-92-7
893420-59-2
1572943-04-4
Tezepelumab
943609-66-3
Vedolizumab
863971-12-4
MMAF-OMe
2534-03-4
1384260-65-4
Aducanumab
2130869-18-8
Mal-PEG2-VCP-Eribulin
1610943-06-0
Emicizumab
More Information:
Check CAS No 1044511-01-4 on External Site
1044511-01-4
benralizumab,1044511-01-4
2025-12-26 Discover Benralizumab (CAS No: 1044511-01-4) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.